Mirum Pharmaceuticals, Inc. (MIRM) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of$0.1 per share. This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +150.00$0.31 per share when it actually produced a loss of $0.12, delivering a surprise of +61.29%.Over the last four quart ...